Saturday, November 27, 2021


FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and syringe are seen in front of displayed Novavax logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Amsterdam, Nov 17 (Prensa Latina) The European Medicines Agency (EMA) began today, at the request of the European Union, the evaluation of the anti-Covid-19 vaccine of U.S. pharmaceutical Novavax.